CLDF Title
Home | Contact Us | Bookmark
MASH HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
Embassy of Education
Webcasts Abstract Library LiverQ Academy National Conference Regional Conferences
 
Back  
 
Reuters Health Information (2010-03-17): WHO, UNICEF suspend use of Shantha Bio's vaccine: report

Regulatory

WHO, UNICEF suspend use of Shantha Bio's vaccine: report

Last Updated: 2010-03-17 19:47:30 -0400 (Reuters Health)

MUMBAI (Reuters) - The World Health Organization (WHO) and UNICEF have suspended the use and purchase of the Shan5 vaccine from Sanofi Aventis owned Shantha Biotechnics pending a quality investigation.

The combination vaccine is given to prevent diphtheria, pertussis, tetanus, haemophilus influenza B, and hepatitis B.

"Countries are advised to put any remaining vaccine in quarantine until further notice," the joint WHO-UNICEF statement said.

The investigation was launched after reports "of a white sediment which sticks to the glass of the vaccine vial that is difficult or impossible to re-suspend with vigorous shaking (flocculation)," the statement says.

WHO has received no reports of adverse reactions so far in those who have been given the vaccine.

An Economic Times report said the pending investigation threatens a three-year contract worth $350 million.

An official of Shantha Biotechnics could not be reached immediately for a comment by Reuters.

(Reporting by Kaustubh Kulkarni)

 
 
 
 

Subscribe

Be the first to know about our latest upcoming programs and events!

CLDF

Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.